| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |